XML 37 R25.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED T. ROWE PRICE INVESTMENT PRODUCTS AND OTHER ENTITIES (Tables)
 3 Months Ended
Mar. 31, 2022
Consolidated Sponsored Investment Portfolios [Abstract]  
Schedule of Net Assets of Consolidated T. Rowe Price Investment Portfolios
The following table details the net assets of the consolidated T. Rowe Price investment products:
3/31/202212/31/2021
(in millions)
Voting
interest entities
Variable interest entities
Total
Voting
interest entities
Variable interest entities
Total
Cash and cash equivalents(1)
$9.5 $77.5 $87.0 $7.3 $93.8 $101.1 
Investments(2)
144.4 1,391.5 1,535.9 188.9 1,645.0 1,833.9 
Other assets3.3 32.0 35.3 5.1 22.7 27.8 
Total assets157.2 1,501.0 1,658.2 201.3 1,761.5 1,962.8 
Liabilities11.7 44.2 55.9 15.3 36.2 51.5 
Net assets$145.5 $1,456.8 $1,602.3 $186.0 $1,725.3 $1,911.3 
Attributable to T. Rowe Price$99.6 $712.3 $811.9 $125.3 $803.7 $929.0 
Attributable to redeemable non-controlling interests45.9 744.5 790.4 60.7 921.6 982.3 
$145.5 $1,456.8 $1,602.3 $186.0 $1,725.3 $1,911.3 
(1) Cash and cash equivalents includes $6.6 million at March 31, 2022, and $6.5 million at December 31, 2021, of T. Rowe Price money market mutual funds.
(2) Investments include $39.3 million at March 31, 2022, and $42.5 million at December 31, 2021 of other T. Rowe Price investment products.
Schedule of Operating Results of Consolidated T. Rowe Price Investment Portfolios
The operating results of the consolidated T. Rowe Price investment products for the three months ended March 31, 2022 and 2021, are reflected in our unaudited condensed consolidated statements of income as follows:
Three months ended
3/31/20223/31/2021
(in millions)
Voting interest entitiesVariable interest entitiesTotalVoting interest entitiesVariable interest entitiesTotal
Operating expenses reflected in net operating income$(.2)$(2.3)$(2.5)$(.2)$(3.3)$(3.5)
Net investment income (loss) reflected in non-operating income (loss)(6.6)(94.8)(101.4)6.1 31.1 37.2 
Impact on income before taxes$(6.8)$(97.1)$(103.9)$5.9 $27.8 $33.7 
Net income (loss) attributable to T. Rowe Price$(4.7)$(45.7)$(50.4)$4.0 $14.3 $18.3 
Net income (loss) attributable to redeemable non-controlling interests(2.1)(51.4)(53.5)1.9 13.5 15.4 
$(6.8)$(97.1)$(103.9)$5.9 $27.8 $33.7 
Schedule of Cash flows of Consolidated T. Rowe Price Investment Portfolios
The table below details the impact of these consolidated investment products on the individual lines of our unaudited condensed consolidated statements of cash flows for the three months ended March 31, 2022 and 2021.
Three months ended
3/31/20223/31/2021
(in millions)
Voting
interest entities
Variable interest entities
Total
Voting
interest entities
Variable interest entities
Total
Net cash provided by (used in) operating activities$(2.6)$88.2 $85.6 $(31.7)$(112.0)$(143.7)
Net cash used in investing activities— (5.9)(5.9)(9.1)(18.2)(27.3)
Net cash provided by (used in) financing activities4.9 (95.9)(91.0)36.7 112.3 149.0 
Effect of exchange rate changes on cash and cash equivalents of consolidated
T. Rowe Price investment products
— (2.7)(2.7)— .9 .9 
Net change in cash and cash equivalents during period
2.3 (16.3)(14.0)(4.1)(17.0)(21.1)
Cash and cash equivalents at beginning of year
7.3 93.8 101.1 7.1 97.7 104.8 
Cash and cash equivalents at end of period
$9.6 $77.5 $87.1 $3.0 $80.7 $83.7 
Schedule of Fair Values of Investments Held by Consolidated T. Rowe Price Investment Portfolios The following table summarizes the investment holdings held by our consolidated T. Rowe Price investment products using fair value measurements determined based on the differing levels of inputs.
3/31/202212/31/2021
(in millions)
Level 1
Level 2
Level 1
Level 2
Assets
  Cash equivalents$6.6 $2.1 $6.5 $.7 
Equity securities212.4 239.0 247.8 340.3 
Fixed income securities— 1,024.6 — 1,187.4 
Other investments8.6 51.3 5.7 52.7 
$227.6 $1,317.0 $260.0 $1,581.1 
Liabilities$(1.9)$(13.1)$(.7)$(9.7)